Prognostic Value of G8 Geriatric Screening and Meet-URO Scores in Metastatic Renal Cell Carcinoma Patients Receiving First-Line Ipilimumab-Nivolumab Combination Immunotherapy

Prognostic Value of G8 Geriatric Screening and Meet-URO Scores in Metastatic Renal Cell Carcinoma Patients Receiving First-Line Ipilimumab-Nivolumab Combination Immunotherapy

Background The prognostic value of the Geriatric 8 (G8) screening score in metastatic renal cell carcinoma (mRCC) patients receiving first-line immunotherapy remains unclear. This study aimed to evaluate the prognostic role of G8 within the context of the Meet-URO classification in mRCC patients tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Ria Nagpal MB, BCh, BAO, Marina Campione PhD, Sara Elena Rebuzzi MD, Lucia Fratino MD, Pasquale Rescigno MD, Sergio Bracarda MD, Davide Bimbatti MD, Ugo De Giorgi MD, Matteo Santoni MD, Fabio Calabrò MD, Mimma Rizzo MD, Alessio Signori PhD, Diana Giannarelli PhD, Giuseppe Fornarini MD, Umberto Basso MD, Giuseppe Luigi Banna MD
Format: Article
Language:English
Published: SAGE Publishing 2025-02-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338251316626
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/15330338251316626

Similar Items